Compare IKT & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IKT | ATLO |
|---|---|---|
| Founded | 2008 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.2M | 253.0M |
| IPO Year | 2020 | 2001 |
| Metric | IKT | ATLO |
|---|---|---|
| Price | $1.67 | $30.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 673.0K | 63.1K |
| Earning Date | 03-26-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.43% |
| EPS Growth | ★ 57.76 | 8.03 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $79.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $16.94 |
| 52 Week High | $2.26 | $30.92 |
| Indicator | IKT | ATLO |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 68.56 |
| Support Level | $1.64 | $27.55 |
| Resistance Level | $1.76 | N/A |
| Average True Range (ATR) | 0.07 | 0.56 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 40.54 | 71.10 |
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.
Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.